University of Hawaii Cancer Center CCSG
University of Hawaii Cancer Center CCSG
批准号:
9526161
负责人:
RANDALL F HOLCOMBE
金额:
$215.6万
依托单位国家:
美国
项目类别:
财政年份:
1997
资助国家:
美国
项目状态:
已结题
起止时间:
1997-07-01 至 2018-06-30
关键词:
AddressAnalytical BiochemistryAnimalsAreaBasic ScienceBiometryBudgetsBurn injuryCancer BiologyCancer BurdenCancer CenterCancer Center Support GrantCancer ControlCancer EtiologyCancer Research Center of HawaiiCharacteristicsClinicalClinical ResearchClinical SkillsClinical TreatmentCollaborationsCultural DiversityDevelopmentEducationEnvironmentEvaluationFacultyFoundationsFundingGenomicsHawaiiHawaiian populationHealthHospitalsInformaticsInstitutionInstructionIslandLeadershipMalignant NeoplasmsMedical centerMissionNCI Center for Cancer ResearchPathologyPatient CarePeer ReviewPeer Review GrantsPopulationPopulation SciencesPositioning AttributeRecruitment ActivityRequest for ApplicationsResearchResearch InfrastructureResearch PersonnelResource SharingServicesSourceSystemTranslational ResearchUniversitiesWorkanticancer researchcancer carecancer clinical trialcancer epidemiologycancer preventioncancer research center directorcancer therapycarcinogenesisclinical Diagnosisethnic diversityhealth disparityhigher educationmedical schoolsmembermicroscopic imagingnovel diagnosticsnovel therapeuticsnutritionpreventprogramsracial diversityresearch facilitytenure tracktranslational cancer research
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): This application seeks renewed CCSG funding for the University of Hawai'i Cancer Center (UHCC), the state of Hawai'i and the Pacific Region's only institution where cancer research is performed. As an outpost in an area of the world with significant health disparities, UHCC serves a critical function in bringing cutting edge basic, translational, and clinical research on how to prevent and treat cancer within reach of the unique regional population. UHCC is part of the new Hawai'i Cancer Consortium (HCC) along with the 3 major hospital systems of Hawai'i. This consortium enables UHCC to develop a new clinical program and expand its clinical and translational research towards the development of new diagnostics and therapies. HCC institutions have committed $2.2 million annually towards UHCC through 2017, and UHCC receives $23.2M from the NCI and $18M from other peer-reviewed sources for a total of $41.2M in overall peer-reviewed grant funding. UHCC/HCC has recently recruited a new Director, along with 30 additional faculty members, who bring with them a broad-spectrum of scientific and clinical skills. These new recruits have helped UHCC/HCC continue to build and strengthen its basic-science foundations and to greatly enhance its ability to accelerate clinical and translational cancer research. To enhance their transdisciplinary and translational research, the three Research Programs (Cancer Biology, Cancer Epidemiology, and Cancer Prevention and Control) have been reorganized to provide a better focus in their areas of research. All Programs at UHCC are led by new Directors, each dedicated to increasing the vitality and interaction of their Programs. In addition, Planning and Evaluation has
been restructured to create more opportunities for investigators to interact and stay abreast of opportunities for collaboration. This application requests support for 7 Shared Resources (Analytical Biochemistry, Biostatistics and Informatics, Genomics, Microscopy and Imaging, Nutrition Support, Pathology, and Clinical and Translational Research Services), and one developing Shared Resource (Animal Carcinogenesis). Major additions in research facilities include a new 150,000-sq ft UHCC research building opening in 2012 that will collectively house our growing faculty, as the University of Hawai'i has approved a total of 18 new tenure track positions for UHCC. This application describes continued excellence in basic and translational cancer research, and greatly strengthened clinical research leadership and infrastructure.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Neoadjuvant photodynamic immunomodulation for colon cancer
-
批准号:8005456
-
项目类别:
-
资助金额:$29.82万
-
财政年份:2010
-
负责人:RANDALL F HOLCOMBE
-
依托单位:
Neoadjuvant photodynamic immunomodulation for colon cancer
-
批准号:8119595
-
项目类别:
-
资助金额:$30.21万
-
财政年份:2010
-
负责人:RANDALL F HOLCOMBE
-
依托单位:
PHASE I BIOMARKER STUDY OF DIETARY GRAPE-DERIVED LOW DOSE RESVERATROL FOR COLON
-
批准号:8166926
-
项目类别:
-
资助金额:$0.02万
-
财政年份:2009
-
负责人:RANDALL F HOLCOMBE
-
依托单位:
PHASE I BIOMARKER STUDY OF DIETARY GRAPE-DERIVED LOW DOSE RESVERATROL FOR COLON
-
批准号:7951074
-
项目类别:
-
资助金额:$6.51万
-
财政年份:2008
-
负责人:RANDALL F HOLCOMBE
-
依托单位:
A Phase 1 Study of CCI-779 in Combination with Imatnib *
-
批准号:7087072
-
项目类别:
-
资助金额:$24.88万
-
财政年份:2005
-
负责人:RANDALL F HOLCOMBE
-
依托单位:
Wnt Signaling in IBD-Related Colon Cancer
-
批准号:6850894
-
项目类别:
-
资助金额:$15.19万
-
财政年份:2004
-
负责人:RANDALL F HOLCOMBE
-
依托单位:
Wnt Signaling in IBD-Related Colon Cancer
-
批准号:6703346
-
项目类别:
-
资助金额:$15.15万
-
财政年份:2004
-
负责人:RANDALL F HOLCOMBE
-
依托单位:
Patient oriented Research--Colon CA & Cancer Immunology
-
批准号:6327470
-
项目类别:
-
资助金额:$12.79万
-
财政年份:2001
-
负责人:RANDALL F HOLCOMBE
-
依托单位:
Patient oriented Research--Colon CA & Cancer Immunology
-
批准号:6874525
-
项目类别:
-
资助金额:$12.7万
-
财政年份:2001
-
负责人:RANDALL F HOLCOMBE
-
依托单位:
Patient-oriented Research: Colon CA & Cancer Immunology
-
批准号:7586771
-
项目类别:
-
资助金额:$14.96万
-
财政年份:2001
-
负责人:RANDALL F HOLCOMBE
-
依托单位:
Patient-oriented Research: Colon CA & Cancer Immunology
-
批准号:7097832
-
项目类别:
-
资助金额:$14.58万
-
财政年份:2001
-
负责人:RANDALL F HOLCOMBE
-
依托单位:
Patient oriented Research--Colon CA & Cancer Immunology
-
批准号:6633466
-
项目类别:
-
资助金额:$12.7万
-
财政年份:2001
-
负责人:RANDALL F HOLCOMBE
-
依托单位:
Patient-oriented Research: Colon CA & Cancer Immunology
-
批准号:7251986
-
项目类别:
-
资助金额:$14.86万
-
财政年份:2001
-
负责人:RANDALL F HOLCOMBE
-
依托单位:
Patient-oriented Research: Colon CA & Cancer Immunology
-
批准号:8182171
-
项目类别:
-
资助金额:$9.12万
-
财政年份:2001
-
负责人:RANDALL F HOLCOMBE
-
依托单位:
Patient-oriented Research: Colon CA & Cancer Immunology
-
批准号:7788097
-
项目类别:
-
资助金额:$5.84万
-
财政年份:2001
-
负责人:RANDALL F HOLCOMBE
-
依托单位:
Patient-oriented Research: Colon CA & Cancer Immunology
-
批准号:7386702
-
项目类别:
-
资助金额:$14.96万
-
财政年份:2001
-
负责人:RANDALL F HOLCOMBE
-
依托单位:
Patient oriented Research--Colon CA & Cancer Immunology
-
批准号:6514090
-
项目类别:
-
资助金额:$12.69万
-
财政年份:2001
-
负责人:RANDALL F HOLCOMBE
-
依托单位:
Patient oriented Research--Colon CA & Cancer Immunology
-
批准号:6726005
-
项目类别:
-
资助金额:$12.7万
-
财政年份:2001
-
负责人:RANDALL F HOLCOMBE
-
依托单位:
University of Hawaii Cancer Center CCSG
-
批准号:9268835
-
项目类别:
-
资助金额:$11.55万
-
财政年份:1997
-
负责人:RANDALL F HOLCOMBE
-
依托单位:
University of Hawaii Cancer Center CCSG
-
批准号:10063281
-
项目类别:
-
资助金额:$11.5万
-
财政年份:1997
-
负责人:RANDALL F HOLCOMBE
-
依托单位:
海外基金